Cargando…
Anti-Mouse CD83 Monoclonal Antibody Targeting Mature Dendritic Cells Provides Protection Against Collagen Induced Arthritis
Antibodies targeting the activation marker CD83 can achieve immune suppression by targeting antigen-presenting mature dendritic cells (DC). This study investigated the immunosuppressive mechanisms of anti-CD83 antibody treatment in mice and tested its efficacy in a model of autoimmune rheumatoid art...
Autores principales: | Silveira, Pablo A., Kupresanin, Fiona, Romano, Adelina, Hsu, Wei-Hsun, Lo, Tsun-Ho, Ju, Xinsheng, Chen, Hsiao-Ting, Roberts, Helen, Baker, Daniel G., Clark, Georgina J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866188/ https://www.ncbi.nlm.nih.gov/pubmed/35222372 http://dx.doi.org/10.3389/fimmu.2022.784528 |
Ejemplares similares
-
CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential
por: Li, Ziduo, et al.
Publicado: (2019) -
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
por: Li, Ziduo, et al.
Publicado: (2018) -
Targeting CD83 in mantle cell lymphoma with anti‐human CD83 antibody
por: Li, Ziduo, et al.
Publicado: (2020) -
Inhibition of Cd83 Cell Surface Expression during Dendritic Cell Maturation by Interference with Nuclear Export of Cd83 mRNA
por: Kruse, Monika, et al.
Publicado: (2000) -
A multi-laboratory comparison of blood dendritic cell populations
por: Fromm, Phillip Dieter, et al.
Publicado: (2016)